JAMA Netw Open:COVID-19患者出院后不仅运动耐量降低,心理也受到创伤!

2021-01-30 MedSci原创 MedSci原创

目前,新冠肺炎(COVID-19)仍在全球肆虐,据数据显示,全球已确诊超1亿258万,累计死亡人数超221.4万。

目前,新冠肺炎COVID-19仍在全球肆虐,据数据显示,全球已确诊超1亿258万,累计死亡人数超221.4万。自COVID-19大流行以来,各国科学家将注意力集中在COVID-19感染急性期的临床特征和预后上。尽管COVID-19是一种全身性疾病,但对其肺功能及其他后遗症类型和严重性尚不清楚。

近日,发表在JAMA Netw Open杂志上的一项研究发现,出院后4个月,COVID-19患者出现常见的呼吸道,身体和心理后遗症。

研究人员对来自意大利北部的一家医院于202031日至629日出院的767名年龄在18岁以上的患者进行前瞻性队列研究,这些患者均接受了住院治疗。研究人员收集了患者的健康记录,住院期间COVID-19诊断的症状以及并发症(回顾性记录)以及合并症的类型和数量的数据,并在出院后的3-4个月通过电话进行随访。

研究结果主要描述了一氧化碳扩散肺容量(Dlco)低于预期值80%的患者比例。次要结果包括严重肺功能损伤患者的比例(定义为Dlco<60%的预期值);创伤后应激症状患者的比例(使用事件影响量表-修订总分测量);功能损伤患者的比例(使用短期体能测试[SPPB]评分和2分钟步行测试评估);以及识别与Dlco减少和心理或功能后遗症相关的因素。

结果显示,在767名因重度COVID-19住院的患者中,494人(64.4%)拒绝参与,35人(4.6%)在随访期间死亡。共有238名患者(31.0%)同意参与此研究。其中,219名患者能够同时完成肺功能检测和Dlco测量。113名患者(51.6%)的Dlco降至估计值的80%以下,34名患者(15.5%)降至60%以下。

在身体功能方面,根据SPPB测试结果,53名患者(22.3%)活动受限。所有其他患者均接受了2分钟的步行测试,其中75名患者(31.5%)有较轻微的损伤。因此,共有128名患者(53.8%)出现功能障碍,而且有50名患者(21.0%),运动的耐受性恶化。

在心理健康方面,17.2%COVID-19幸存者出现创伤后应激障碍,而且男性是与PTS症状相关的唯一独立因素。由于该研究的心理评估仅限于PTS症状,无法就COVID-19的整体心理影响得出明确的结论,其中可能包括睡眠障碍,焦虑和抑郁等。

总之,在这项队列研究中,在出院后直至4个月内,仍有很大比例患者与COVID-19相关的症状,其中最常见的是运动耐量降低。此外,COVID-19其他后遗症,例如呼吸和身体功能障碍,可能会影响个体心理健康。肺损伤可能与COVID-19幸存者的生活质量下降有关。

原始出处

Mattia Bellan, MD, PhD; Daniele Soddu, MD; Piero Emilio Balbo, MD; et al.Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge.JAMA Netw Open. 2021;4(1):e2036142. doi:10.1001/jamanetworkopen.2020.36142

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1734303, encodeId=cb831e3430319, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Thu Aug 26 05:37:18 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728803, encodeId=5cf51e2880323, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Apr 30 19:37:18 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1297511, encodeId=4a1c129e51149, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5134, encryptionId=c0385134ab, topicName=COVID-19患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Mon Feb 01 03:37:18 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335325, encodeId=2ed1133532508, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Mon Feb 01 03:37:18 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036427, encodeId=9f26103642e03, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sat Jan 30 15:37:18 CST 2021, time=2021-01-30, status=1, ipAttribution=)]
    2021-08-26 canlab
  2. [GetPortalCommentsPageByObjectIdResponse(id=1734303, encodeId=cb831e3430319, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Thu Aug 26 05:37:18 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728803, encodeId=5cf51e2880323, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Apr 30 19:37:18 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1297511, encodeId=4a1c129e51149, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5134, encryptionId=c0385134ab, topicName=COVID-19患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Mon Feb 01 03:37:18 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335325, encodeId=2ed1133532508, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Mon Feb 01 03:37:18 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036427, encodeId=9f26103642e03, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sat Jan 30 15:37:18 CST 2021, time=2021-01-30, status=1, ipAttribution=)]
    2021-04-30 feather89
  3. [GetPortalCommentsPageByObjectIdResponse(id=1734303, encodeId=cb831e3430319, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Thu Aug 26 05:37:18 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728803, encodeId=5cf51e2880323, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Apr 30 19:37:18 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1297511, encodeId=4a1c129e51149, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5134, encryptionId=c0385134ab, topicName=COVID-19患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Mon Feb 01 03:37:18 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335325, encodeId=2ed1133532508, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Mon Feb 01 03:37:18 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036427, encodeId=9f26103642e03, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sat Jan 30 15:37:18 CST 2021, time=2021-01-30, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1734303, encodeId=cb831e3430319, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Thu Aug 26 05:37:18 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728803, encodeId=5cf51e2880323, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Apr 30 19:37:18 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1297511, encodeId=4a1c129e51149, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5134, encryptionId=c0385134ab, topicName=COVID-19患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Mon Feb 01 03:37:18 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335325, encodeId=2ed1133532508, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Mon Feb 01 03:37:18 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036427, encodeId=9f26103642e03, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sat Jan 30 15:37:18 CST 2021, time=2021-01-30, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1734303, encodeId=cb831e3430319, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Thu Aug 26 05:37:18 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728803, encodeId=5cf51e2880323, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Apr 30 19:37:18 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1297511, encodeId=4a1c129e51149, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5134, encryptionId=c0385134ab, topicName=COVID-19患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Mon Feb 01 03:37:18 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335325, encodeId=2ed1133532508, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Mon Feb 01 03:37:18 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036427, encodeId=9f26103642e03, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sat Jan 30 15:37:18 CST 2021, time=2021-01-30, status=1, ipAttribution=)]
    2021-01-30 旺医

    顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息

    0

相关资讯

脑卒中后遗症的护理

脑出血和脑梗死统称为脑卒中。2005~2007年我国抽样统计九个大城市称,脑卒中疾病年发病率为170.85/10万,男性为201.8/10万,女性为139.9/10万,男女比率为3︰2。年死亡率为23.4%,是急性心梗的4倍,致残率为78.4%,三年内复发率为43%。脑卒中严重危害人的身体健康和生命,因此,预防脑中风和急性期抢救治疗很重要,但脑卒中后遗症期也不得不花时间花精力,科学应对。

NEJM:埃博拉病毒幸存者后遗症分析

由此可见,所有参与者都出现了相对较高的症状负担,但某些症状和检查结果在幸存者中更常见。除葡萄膜炎外,两组患者在随访期间患病率均有所下降。精液中的病毒RNA持续时间最多40个月。

Am J Med:加压弹力袜真的能降低深静脉血栓风险吗?

研究者进行了一项荟萃分析,探究加压弹力袜对下肢深静脉血栓患者的利弊。荟萃分析共纳入了5篇关于下肢深静脉血栓形成后遗症的随机对照试验。荟萃分析结果显示,加压弹力袜对下肢深静脉血栓形成后遗症的风险HR=0.69 (95% CI, 0.47-1.02)。因为纳入的研究间具有异质性、纳入了偏倚风险高的非盲试验,所以该荟萃分析结果可信度低。排除偏倚风险高的研究后,一篇大型的低偏倚风险的随机对照试验表明(中等

康复治疗可缓解脑出血后遗症

脑出血后通过康复治疗能够缓解手脚麻痹。日本一项研究发现,这是因为通过集中的康复治疗,其他神经会取代受损的神经形成新的神经回路,从而促进了运动机能的恢复。 大脑皮质运动区发出的命令通过神经回路经由脊髓传递到手脚,如果这个神经回路因为脑出血而被切断,就会出现手脚麻痹。此前已知康复治疗有助于恢复麻痹的手脚功能,但是其具体机制一直不清楚。 日本自然科学研究机构生理学研究所与名古屋市立大学研究人

Neurology:Zika感染患者的长期结果研究

Zika神经综合症是一组异质的临床神经学表现,脑神经麻痹和混合性神经疾病是其主要的临床表现,大部分患者存在长期后遗症

Lancet Infect Dis:病毒性脑膜炎:发病率、病因、后遗症

在英国,病毒性脑膜炎的发生率、病因及结局知之甚少。2018年9月,发表在《Lancet Infect Dis》的一项多中心、前瞻性、观察性、队列研究调查了英国成人病毒性脑膜炎的发病率、病因和后遗症。